Long-term ethanol exposure causes human liver cancer cells to become resistant to mitomycin C treatment through the inactivation of bad-mediated apoptosis

Molecular Carcinogenesis
Ching-Shui HuangYuan-Soon Ho

Abstract

The aim of this study was to test whether long-term ethanol consumption confers therapeutic resistance to human liver cancer patients infected with hepatitis B virus (HBV). Chronic ethanol-treated cells were established by consecutively culturing a human hepatocellular carcinoma cell line, Hep 3B, which contains integrated HBV sequences, for 20-40 passages with or without 10 mM ethanol (designated as E20-E40 and C20-C40, respectively). Flow cytometry analysis demonstrated that a growth promoting effect of long-term ethanol treatment was induced in the E40 cells through preferential acceleration of S-phase in these cells. Lower protein expression levels of p16, p21/Cip1, and p27/Kip1 were detected in the ethanol-treated E40 cells. We further demonstrated that long-term ethanol-treated E40 cells develop drug resistance in response to mitomycin C (MMC) treatment (>8 microM). Immunoblot analysis revealed that caspase-8-mediated mitochondrial apoptotic signals (such as Bad) were inactivated in the MMC-resistant E40 cells. Immunoprecipitation experiments demonstrated that the sequestration of phosphorylated Bad (Ser-112) through its binding with 14-3-3 was detected more profoundly in the MMC-resistant E40 cells. Next, we examined the...Continue Reading

References

Mar 1, 1988·Annals of Internal Medicine·A M Di BisceglieM T Lotze
Jan 1, 1988·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·E D AdickesS K Lockwood
Feb 1, 1987·British Heart Journal·J PoultonJ V De Giovanni
Aug 1, 1983·Clinical Pharmacology and Therapeutics·J W GyvesS Walker
Feb 27, 1999·Toxicological Sciences : an Official Journal of the Society of Toxicology·S KorourianT M Badger
Mar 22, 2002·The Lancet Oncology·D M Parkin
Mar 30, 2002·Alcoholism, Clinical and Experimental Research·David B Couch, Rodney C Baker
Jan 7, 2003·The Journal of Nutrition·Xiang-Dong Wang
Jun 10, 2003·International Journal of Cancer. Journal International Du Cancer·Wen-Sen LeeYuan-Soon Ho
Mar 6, 2004·Pharmacological Reviews·Martijn RooseboomNico P E Vermeulen
Apr 2, 2004·Toxicological Sciences : an Official Journal of the Society of Toxicology·Judy L RaucyVeronica Zoleta
Mar 15, 2005·Clinics in Liver Disease·Michael D Voigt
Mar 3, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yean-Hwei ChouChih-Hsiung Wu
Apr 17, 2007·The Lancet Oncology·Robert BaanUNKNOWN WHO International Agency for Research on Cancer Monograph Working Group
Mar 29, 2008·Methods in Molecular Biology·Gavin E Arteel
Apr 9, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yongke LuArthur I Cederbaum
Jun 4, 2008·Journal of Neuroscience Research·Jae Yoon HanWan Sung Choi
Nov 11, 2008·Chemico-biological Interactions·Carlos Henrique LopezAdelar Bracht
Jan 7, 2009·International Journal of Cancer. Journal International Du Cancer·Chih-Hsiung WuShyr-Yi Lin
Feb 25, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elisa V Bandera, David A August
Mar 11, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Hui-Chen WuRegina M Santella
Apr 24, 2009·Seminars in Liver Disease·Iain H McKillop, Laura W Schrum
Jul 10, 2009·The Journal of Pharmacology and Experimental Therapeutics·Bernard FromentyMarie-Anne Robin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis